Skip to main content

Security report for viapharma.cz

ViaPharma s.r.o. · Healthcare · Czech Republic

Medium risk. 6 critical or high findings in GDPR outside view and SSL/TLS.

Security score

64/100

Risk levelMedium

0–100, higher is better. How it is calculated

ViaPharma s.r.o. is a Czech pharmaceutical distribution company operating multiple modern distribution centers to supply pharmacies and hospitals with medicinal products. The company positions itself as a leading distributor in the Czech healthcare market, emphasizing compliance with good distribution practices and reliable supply chain management. The website provides business-relevant content including news updates related to pharmaceutical regulations and product safety. Technically, the website is built on legacy ASP.NET Web Forms technology, hosted behind Cloudflare DNS services, and uses Google Analytics for visitor tracking. The site is moderately optimized for performance and accessibility but lacks advanced mobile responsiveness and modern SEO features. Security practices are basic, with HTTPS implied but no visible security headers or advanced protections. The login form for clients is present but lacks visible anti-CSRF tokens or multi-factor authentication. Security posture is moderate with room for improvement in implementing security headers, modern authentication mechanisms, and privacy compliance. The absence of privacy and cookie policies is a notable compliance gap, especially under GDPR regulations. The domain registration is consistent and trustworthy, with a domain age appropriate for the business history. Overall, the website is functional and professional but would benefit from enhanced security measures, privacy compliance improvements, and technical modernization to strengthen trust and regulatory adherence.

Scanned

NIS2 and GDPR posture

GDPR outside view
10/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

6 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

    • High

      Third-party services without privacy policy

      Detected services: Google Analytics

      What to do: Document all third-party data sharing in your privacy policy

Need hands-on remediation? Email guard@offseq.com

Keep watching viapharma.cz

This scan found 17 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
77
Security headers
70
Email security
100
DNS health
85
Network security
40
GDPR outside view
10
Average
64

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

ViaPharma operates in the healthcare sector as a pharmaceutical distributor with a medium-sized footprint in the Czech Republic. Its competitive advantage lies in its multiple distribution centers and adherence to good distribution practices, ensuring reliable supply of medicinal products. The business model focuses on B2B supply chain services targeting pharmacies and hospitals. The company maintains a partnership ecosystem with regulatory bodies, as evidenced by links to official Czech pharmaceutical regulatory sites. Growth indicators include regular updates on regulatory news and expansion of distribution centers. The company does not publicly disclose parent or subsidiary relationships on the website.

Security posture

The current security maturity level is basic to moderate. The website uses HTTPS and Cloudflare DNS but lacks critical security headers such as CSP, HSTS, and X-Frame-Options. The login form is password protected but does not show advanced protections like anti-CSRF tokens or multi-factor authentication. There is no visible incident response or vulnerability disclosure information. GDPR compliance is incomplete due to missing privacy and cookie policies. The use of legacy ASP.NET Web Forms may expose the site to known vulnerabilities if not properly patched. Overall, the security posture requires enhancements to meet modern standards and regulatory requirements.

Recommendations

  1. Implement comprehensive privacy and cookie policies with explicit GDPR compliance statements.
  2. Add and enforce security headers including Content-Security-Policy, Strict-Transport-Security, X-Frame-Options, and X-Content-Type-Options.
  3. Modernize the web application framework or ensure all security patches for ASP.NET Web Forms are applied.
  4. Enhance login security by adding anti-CSRF tokens and multi-factor authentication.
  5. Establish and publish an incident response policy and vulnerability disclosure program to improve transparency and trust.

Contact details published on the site

Addresses
Legal name
ViaPharma s.r.o.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
ViaPharma s.r.o.
Description
ViaPharma s.r.o. is a leading pharmaceutical distributor in the Czech Republic, operating three modern distribution centers in Pavlov u Kladna, Brno, and Ostrava. The company provides comprehensive supply services to pharmacies and hospitals, ensuring reliable delivery of medicinal products in compliance with good distribution practices.
Key services
Distribution of medicinal products, Supply chain management, Customer ordering system
Content quality
good
Branding
consistent

Technology

Stack
ASP.NET Web Forms, Cloudflare DNS, Google Analytics
Frameworks
ASP.NET
Performance
moderate
Mobile
basic
Accessibility
basic
SEO
basic

Security

Observed score
55/100
Good practices seen
  • Use of HTTPS (implied by Cloudflare DNS and Google Analytics HTTPS script)
  • Login form with password field

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
poor

Advertising

Transparency
poor

Site quality

Design
basic
User experience
basic
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website is fully accessible with no blocking or WAF challenges.
  2. No privacy or cookie policies found, which is a compliance gap.
  3. Login form present for client ordering system but lacks visible advanced security features.
  4. Content is focused on pharmaceutical distribution with regular updates linking to official regulatory sites.
  5. No social media links or direct contact emails/phone numbers explicitly listed on homepage.
  6. Use of legacy ASP.NET Web Forms technology indicates potential modernization opportunity.
  7. Google Analytics used for tracking without visible cookie consent mechanism.
Technical notes

Notes

The website is built on ASP.NET Web Forms, a legacy Microsoft web framework, indicating potential technical debt. Hosting is behind Cloudflare DNS, which provides DNS-level protection but no explicit WAF detected. Google Analytics is used for visitor tracking via the classic ga.js script. The site lacks modern SEO meta tags and structured data such as JSON-LD or Open Graph tags. Performance is moderate with no explicit mobile optimization or accessibility features beyond basic HTML form controls. The site would benefit from modernization to a more current web framework, improved mobile responsiveness, and enhanced SEO and accessibility compliance.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with viapharma.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review viapharma.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.